AU7263300A - Opaminergic neuronal survival-promoting factors and uses thereof - Google Patents
Opaminergic neuronal survival-promoting factors and uses thereofInfo
- Publication number
- AU7263300A AU7263300A AU72633/00A AU7263300A AU7263300A AU 7263300 A AU7263300 A AU 7263300A AU 72633/00 A AU72633/00 A AU 72633/00A AU 7263300 A AU7263300 A AU 7263300A AU 7263300 A AU7263300 A AU 7263300A
- Authority
- AU
- Australia
- Prior art keywords
- opaminergic
- neuronal survival
- promoting factors
- promoting
- factors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0619—Neurons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/08—Coculture with; Conditioned medium produced by cells of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Marine Sciences & Fisheries (AREA)
- General Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15466899P | 1999-09-16 | 1999-09-16 | |
US60/154668 | 1999-09-16 | ||
PCT/CA2000/001049 WO2001019851A2 (en) | 1999-09-16 | 2000-09-18 | Opaminergic neuronal survival-promoting factors and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7263300A true AU7263300A (en) | 2001-04-17 |
Family
ID=22552259
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU72633/00A Abandoned AU7263300A (en) | 1999-09-16 | 2000-09-18 | Opaminergic neuronal survival-promoting factors and uses thereof |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1220681A2 (en) |
JP (1) | JP2003511352A (en) |
AU (1) | AU7263300A (en) |
CA (1) | CA2383076A1 (en) |
MX (1) | MXPA02002765A (en) |
WO (1) | WO2001019851A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2403804A1 (en) * | 2000-03-21 | 2001-09-27 | Curagen Corporation | Vegf-modulated genes and methods employing them |
JP2004528835A (en) * | 2001-03-20 | 2004-09-24 | プレサイエント・ニューロファーマ・インコーポレイテッド | Dopaminergic neuron survival promoting factor and its use |
US7452969B2 (en) | 2002-08-30 | 2008-11-18 | Licentia Ltd | Neurotrophic factor protein and uses thereof |
WO2005005471A2 (en) | 2003-07-11 | 2005-01-20 | Develogen Aktiengesellschaft | Use of dg153 secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
PL1969003T3 (en) | 2005-12-14 | 2011-05-31 | Herantis Pharma Plc | Uses of a NEUROTROPHIC FACTOR PROTEIN |
FI20080326A0 (en) | 2008-04-30 | 2008-04-30 | Licentia Oy | Neurotrophic factor MANF and its uses |
GB0908934D0 (en) * | 2009-05-26 | 2009-07-01 | Univ The West Of Scotland | Differentiation medium |
WO2015149005A1 (en) * | 2014-03-28 | 2015-10-01 | Buck Institute For Research On Aging | Methods and compositions for modulating the immune system |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1219839B (en) * | 1988-02-08 | 1990-05-24 | Fidia Farmaceutici | PURIFICATION, CHARACTERIZATION AND APPLICATION OF A NEURONOTROPHIC FACTOR DERIVED FROM NAMMIFEROUS BRAIN |
US5229500A (en) * | 1989-08-30 | 1993-07-20 | Regeneron Pharmaceuticals, Inc. | Brain derived neurotrophic factor |
CA2148138C (en) * | 1992-10-28 | 2002-01-08 | Samuel Weiss | Biological factors and neural stem cells |
WO1996033731A1 (en) * | 1995-04-26 | 1996-10-31 | Regeneron Pharmaceuticals, Inc. | Methods of using neurotrophic factors to enhance neuronal grafts |
US6222022B1 (en) * | 1996-03-14 | 2001-04-24 | Washington University | Persephin and related growth factors |
-
2000
- 2000-09-18 MX MXPA02002765A patent/MXPA02002765A/en not_active Application Discontinuation
- 2000-09-18 WO PCT/CA2000/001049 patent/WO2001019851A2/en not_active Application Discontinuation
- 2000-09-18 AU AU72633/00A patent/AU7263300A/en not_active Abandoned
- 2000-09-18 CA CA002383076A patent/CA2383076A1/en not_active Abandoned
- 2000-09-18 EP EP00960250A patent/EP1220681A2/en not_active Withdrawn
- 2000-09-18 JP JP2001523628A patent/JP2003511352A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2003511352A (en) | 2003-03-25 |
EP1220681A2 (en) | 2002-07-10 |
WO2001019851A2 (en) | 2001-03-22 |
WO2001019851A3 (en) | 2001-09-20 |
MXPA02002765A (en) | 2005-09-08 |
CA2383076A1 (en) | 2001-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4208799A (en) | Interleukins-21 and 22 | |
AU6241698A (en) | Tace-like and matrilysin-like polypeptides | |
AU4161899A (en) | Radiotherapeutical device and use thereof | |
AU7687298A (en) | Dihydropyrimidines and uses thereof | |
AU9781998A (en) | Huchordin and uses thereof | |
AU1540001A (en) | Fluorene-perylene copolymers and uses thereof | |
AU7612000A (en) | Mono- and bis-indolylquinones and prophylactic and therapeutic uses thereof | |
AU3753599A (en) | Micro-compartmentalization device and uses thereof | |
AU4198299A (en) | Compounds and uses thereof | |
AU6636598A (en) | Novel 3,4-dialkoxyphenyl derivatives and the use thereof | |
AU7073800A (en) | Novel plexins and uses thereof | |
HUP0001603A3 (en) | Cycloalkylalkanecarboxamides and the production and use thereof | |
AU2841801A (en) | Triazolotriazinones and the use thereof | |
AU2418499A (en) | Org-5222 in the treatment of depression | |
AU9469098A (en) | Locking device | |
AU4776800A (en) | Acetylcholinesterase-derived peptides and uses thereof | |
AU7263300A (en) | Opaminergic neuronal survival-promoting factors and uses thereof | |
AU8695298A (en) | Compounds and uses thereof | |
AU8486098A (en) | Waterproof connector and waterproofing-housing member used in the same | |
AU6277699A (en) | Guarantee 20 | |
AU2399601A (en) | Novel tachykinin-like polypeptides and use thereof | |
AU4629399A (en) | Substituted piperazones and their therapeutic uses | |
AU5979300A (en) | Angiopoietin-6 and uses thereof | |
AU2669201A (en) | Taccalonolides and their use | |
AU3086200A (en) | Eyesight-correction and/or eye-training device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |